FDA`s Oversight of Mobile Medical Applications (`apps`) for Use on Smartphones and Similar Mobile Devices 2013 is a webinar that covers topics such as:
- The criteria for distinguishing between regulated and unregulated mobile medical apps
- FDA’s regulation of mobile medical apps
- The July 2011 Mobile Medical App Draft Guidance Document
- Discussion of the responsibilities of a regulated entity
- Identification of application FDA regulations, guidance documents and other relevant documents
- What regulatory requirements must a manufacture comply with to market a regulated app
FDA`s Oversight of Mobile Medical Applications (`apps`) for Use on Smartphones and Similar Mobile Devices 2013 brings together:
- Medical device and Biotech Companies, Start-ups, Foreign Device Manufacturers, Importers, Device Reprocessors; Mobile and Smartphone Companies; the Telecom Industry
- Regulatory Affairs Professionals, Managers, Consultants, Scientists, Research Analysts, State Policy Officials, Insurers focusing on Representations & Warranties Insurance; Investment Analysts; Venture Capitalists
- Financial analysts and investors watching the pharmaceutical, life sciences and biotech industries
